NEWS & INSIGHTS

THE LATEST FROM CND

Check out our news releases, coverage of CND in the media, and our CND Insights blog.

NEWS

In the News
August 31, 2020

CND Founders’ Research in the New York Times

Drs. Christopher Gibbons and Roy Freeman--two of the founders of CND Life Sciences who also…
News Release
May 1, 2020

Mitsubishi Tanabe Pharma America Sponsors CND Life Sciences’ Study

CND will use its novel cutaneous neurodiagnostics platform to detect and measure changes in TDP-43…
News Release
April 2, 2020

CND Life Sciences Forms to Advance Diagnostic and Therapeutic Solutions

Company launches the Syn-One Test™ as the first commercially available skin-based test to help physicians…

INSIGHTS

For Clinicians: Request a Syn-One Test™ Kit

The Syn-One Test provides objective pathological evidence to aid in the diagnosis of a synucleinopathy. Simply collect three small punch skin biopsies from your patient, send them to our CLIA-certified lab, and CND Life Sciences will provide important visual insights to support a diagnosis. If you are a clinician, click below to order a Syn-One Test Biopsy Kit.

Order a Kit